EyewireTV

04.17.2024

Watch Episode

Stocks

Sort by:

Change A-Z

AbbVie $166.40 1.05%

Adverum Biotechnologies $11.34 1.70%

Alcon $79.53 1.35%

Aldeyra Therapeutics $3.87 -2.89%

Alimera Sciences $3.41 -0.87%

Apellis Pharmaceuticals $47.53 0.04%

Astellas Pharma $9.47 0.11%

Bausch + Lomb $14.63 2.16%

Bausch Health Companies $8.70 1.16%

Bayer $7.04 -0.21%

Biogen $194.39 2.03%

Can-Fite Biopharma $1.99 1.02%

Clearside Biomedical $1.29 -2.27%

Cooper Companies $90.42 0.01%

Eyenovia $0.57 7.36%

EyePoint Pharmaceuticals $17.67 0.94%

Glaukos $96.45 1.39%

Harrow Health $10.43 -3.87%

Hill-Rom $155.96 0.03%

Horizon Therapeutics $116.30 0.00%

InMed Pharmaceuticals $0.29 -3.64%

Iridex Corporation $2.95 -2.32%

Johnson & Johnson $147.91 1.49%

Kala Pharmaceuticals $6.81 0.00%

Kiora Pharmaceuticals $0.50 -1.57%

Lensar $3.13 -0.32%

Lineage Cell Therapeutics $1.15 -4.58%

MeiraGTx Holdings $5.09 1.60%

Merck & Company $125.87 0.51%

National Vision Holdings $18.79 0.37%

NovaBay Pharmaceuticals $0.08 -1.90%

Novartis AG Common Stock $94.36 1.93%

Ocugen $1.32 -0.38%

Ocular Therapeutix $5.22 -10.92%

Oculis $11.78 0.00%

Ocuphire Pharma $1.66 -0.60%

Omeros Corp. $3.05 -5.14%

Osmotica $1.11 -1.77%

Outlook Therapeutics $8.15 -1.69%

Palatin Technologies $1.85 -2.38%

Regeneron $896.42 0.27%

Regenxbio $15.66 -2.79%

Roche $30.41 1.20%

Sight Sciences $5.12 -2.29%

STAAR Surgical Company $46.39 -0.81%

Takeda Pharmaceutical Company $13.25 0.65%

Tarsus Pharmaceuticals $32.41 -1.35%

Viatris $11.25 1.17%

View More Stocks

Cataract

Dead Bag Syndrome

Lilianna Werner, MD, PhD; Jason Jones, MD; Nicole Fram, MD; Gregory Ogawa, MD; Samuel Masket, MD; and Nick Mamalis, MD

Eyetube

Capsular Bag: A New Site for Drug Delivery

Robert H. Osher, MD

Eyetube

Dense Cataract in Pseudoexfoliation Syndrome

Marisa Schoen, MD

Eyetube

A Model for Green Cataract Surgery

Kannusamy Veena, MD; Snigdha Mishra, MD; Rengaraj Venkatesh, MD

Eyetube

Artificial Intelligence Assisted Eye Care

Shail Vasavada, MD; Samaresh Srivastava, MD; Ashok Puri, MD; Vaishali Vasavada, MD; and Abhay Vasavada, MD

Eyetube

The Consumer Journey in Vision Correction

Insights from the Refractive Surgery Council.

Liana Miller and Lisa Spicer

Cataract and Refractive Surgery Today

BVI’s Podeye Hydrophobic Monofocal IOL Launched in Japan

Eyewire News

Ocular Therapeutix Names Pravin U. Dugel, MD, President and CEO

Eyewire News

Robotic Cataract Surgery Using ForSight Robotics’ Oryom Platform Presented for the First Time at ASCRS

Eyewire News

Oasis Medical Introduces SOFT PLUG Extended Duration 180-T Tapered Plug

Eyewire News

Refractive

Essential Preoperative Considerations

Clinical examination findings and diagnostic imaging are critical to success.

Tanya Trinh, MBBS, FRANZCO, FWCRS, and Nicole Fram, MD

Cataract and Refractive Surgery Today

Middle segment surgery includes a broad spectrum of anterior segment surgical and reconstructive procedures. These cases present unique challenges and great variety, requiring the ophthalmologist to anticipate diverse surgical scenarios. Preparation is key. Surgical technique is tailored to each specific case. A comprehensive examination of both the anterior and posterior segments is essential to devising a primary surgical strategy and alternative approaches. Complex procedures such as traumatic cataract with zonulopathy, IOL exchange in the setting of an open capsule, repositioning of a subluxated IOL, and/or secondary IOL placement with scleral fixation require safety, accuracy, and reproducibility. Understanding how to handle vitreous prolapse, clear the area of potential vitreous traction, and visualize the middle segment for safe fixation of an IOL is paramount. Fortunately, simulation models are available to practice techniques such as pars plana–assisted anterior vitrectomy and scleral fixation. This preparation can give the surgeon experience and muscle memory to have a deliberate technique and add confidence to perform safe and accurate surgery. The preoperative clinical examination is a crucial step in assessing a patient’s visual potential and preparing for surgery.

The Consumer Journey in Vision Correction

Insights from the Refractive Surgery Council.

Liana Miller and Lisa Spicer

Cataract and Refractive Surgery Today

High Astigmatism With Underlying Ectasia

What are the options for reducing the patient’s spectacle dependence?

Priya M. Mathews, MD, MPH; Kanika Agarwal, MD; and Francis W. Price Jr, MD

Cataract and Refractive Surgery Today

Synergizing Anterior and Posterior Expertise

Collaborating to improve patient outcomes.

Murtaza Adam, MD

Cataract and Refractive Surgery Today

Shaking Things Up

Cataract surgeons discuss their approach to a reluctant patient with nystagmus and amblyopia.

Neda Nikpoor, MD; P. Dee G. Stephenson, MD, FACS; and Gary Wörtz, MD

Cataract and Refractive Surgery Today

Treating Astigmatism With Femtosecond Laser

Omar F. Almallah, MD

Eyetube

04.15.2024

Ocular Therapeutix Names Pravin U. Dugel, MD, President and CEO

Eyewire News

04.11.2024

First Patient Enrolled in LYNX-2 Phase 3 Study Evaluating Phentolamine for the Treatment of Decreased VA Under Low Light Conditions Following Keratorefractive Surgery

Eyewire News

04.09.2024

Oasis Medical Introduces SOFT PLUG Extended Duration 180-T Tapered Plug

Eyewire News

04.04.2024

Zeiss Completes Acquisition of Dutch Ophthalmic Research Center (DORC)

Eyewire News

Stay Updated

Retina

Tailoring IVT Dosing With Vitreous Volume

We have heard the adage, “As much as necessary, as little as possible,” with regard to medication. Can we apply it to intravitreal therapy?

Andreas F. Borkenstein, MD

Retina Today

The vitreous humor, which makes up approximately 80% of the eye, provides nutrients, maintains the eye’s shape and structure, and helps to ensure clear vision.

Managing Large Macular Holes: ILM Flap vs Peel

The literature continues to identify scenarios in which one technique is more effective than the other.

Kaitlyn Richards, BS, and Ankoor R. Shah, MD

Retina Today

New Retina Radio Journal Club with VBS: Comparison of Antiseptics Use for IVT

Sruthi Arepalli, MD, Vaidehi Dedania, MD, and Rebecca Soares, MD, MPH

Eyetube

Acute-Onset Vogt-Koyanagi-Harada Syndrome

This autoimmune condition may present with only ocular findings early in the disease course.

Steven Scheidt, MS, and Heeral R. Shah, MD

Retina Today

A Reference Guide for OCT Angiography

An illustrative overview of OCTA findings to help you implement this tool in common clinical scenarios.

Ivy Zhu, MD; Nicole L. Decker, BS; and Amani A. Fawzi, MD

Retina Today

Research Considerations During Retina Fellowship

Two fellows offer their pearls to help others start their research journey.

Olufemi Adams, MD

Retina Today

04.19.2024

Ocugen Completes Dosing in Phase 1/2 Trial of OCU410 for Geographic Atrophy

Eyewire News

04.18.2024

Ocular Therapeutix Releases Topline Results for Phase 1 Trial of Axpaxli for Diabetic Retinopathy

Eyewire News

04.16.2024

Regeneron Backs $500 Million Venture Capital Fund for Biotechnology Innovation

Eyewire News

04.15.2024

iHealthScreen Awarded US Patent on Glaucoma Detection Based on AI and Color Fundus Imaging

Eyewire News

Glaucoma

Is Glaucoma Policy Short-Sighted?

Redefining innovation to keep an eye on patient access.

Sara Riaz, MSc; Blake Oberfeld, MD; Hani El Helwe, MD; Henisk Falah, BS; and David Solá-Del Valle, MD

Glaucoma Today

Glaucoma is an incurable disease and a leading cause of blindness that is expected to affect up to 120 million people by 2040.1 In the United States, glaucoma specialists complete at least 13 years of rigorous training to manage this prevalent disease, yet reimbursement for glaucoma care is largely dictated by US health insurance payers. Last year, multiple Medicare Administrative Contractors (MACs) announced that they would no longer cover several MIGS procedures. Ultimately, lobbying by patient advocacy groups, glaucoma specialists, and ophthalmology societies, among others, led to the reversal of this controversial coverage policy.2 Nevertheless, other modern and effective glaucoma treatments such as certain standalone and combined MIGS procedures, drug delivery systems, new antiglaucoma medications, and preservative-free antiglaucoma drugs remain at risk of coverage restrictions. When insurers do not cover costs, patients must either pay out of pocket or lose access, potentially worsening inequities in eye care.3 Health care policy plays a crucial role in controlling the costs of care at a population level. However, policies guiding glaucoma care should also account for the lack of curative therapies, the limitations of feasible research, patient-specific factors directing treatment, and the burden of patient nonadherence. In this sense, we would argue that, for glaucoma policy, reimbursement rules should not be designed to discourage research and innovation and that, for ophthalmologists, innovation should not stop at the development of new drugs and devices. To balance care and costs, innovation should continue through the long-term study of cost-effectiveness and quality-of-life improvements that existing glaucoma drugs and devices can offer. With the help of industry and government, ophthalmologists should be ready to lead data-driven policy reform, ensuring that patients can access the care they need and deserve. AT A GLANCE Glaucoma policy determinations may be failing to meet the goals of patients and practitioners as well as the overall policy goal of controlling costs. The ophthalmology community and policymakers must take innovation a step further by studying the long-term cost-effectiveness of existing treatments and the impact that restrictive coverage policies can have on patient quality of life.

Hydrus Microstent Removal and Repositioning

I. Paul Singh, MD

Eyetube

Ethical Global Outreach in Residency Training

Acknowledging how self-interest, altruism, and global health experiences intersect.

Grace Sun, MD, and Alina Husain, BS

Glaucoma Today

Seen & Heard

Glaucoma Today

Ahmed DVX Prism for ORA and Hydrus Cases

Arkadiy Yadgarov, MD

Eyetube

Screening and Establishing a Diagnosis With OCT

Closer consideration of nonglaucomatous conditions is warranted.

Sanjay Asrani, MD

Glaucoma Today

04.15.2024

iHealthScreen Awarded US Patent on Glaucoma Detection Based on AI and Color Fundus Imaging

Eyewire News

04.15.2024

Ocular Therapeutix Names Pravin U. Dugel, MD, President and CEO

Eyewire News

04.11.2024

Sight Sciences Announces the Publication of Large-Scale, Real-World MIGS Study Demonstrating Aqueous Outflow Restorative Procedure with OMNI

Eyewire News

04.09.2024

Oasis Medical Introduces SOFT PLUG Extended Duration 180-T Tapered Plug

Eyewire News

Featured Podcasts

Ophthalmology off the Grid

Open. Outspoken. It's Ophthalmology off the Grid—an honest look at controversial topics in the field.

View Feed

New Retina Radio

New Retina Radio is a place to hear stories about retina that are told nowhere else.

View Feed

Pupil Pod

A case-based podcast hosted by Sila Bal, MD, MPH, featuring all stages of the journey through ophthalmology, from first-year residents to the leading experts.

View Feed

Optometry

Papilledema Associated With Meningioma

Even if you suspect idiopathic intracranial hypertension, it’s important to order appropriate imaging and workup to rule out more serious causes of papilledema.

Christopher J. Borgman, OD, FAAO, and Rick Savoy, OD, MPH

Modern Optometry

A 45-year-old Black female was referred to us for a second opinion on possible edematous optic nerves after being seen 1 week earlier. The patient reported having headaches that worsened over the past year. She denied trauma and changes to her vision; her ocular history was unremarkable. She also denied systemic medical issues and allergies and was taking only a daily multivitamin. EXAMINATION FINDINGS The patient’s entering VA was 20/20 OU. Her pupils were equal, round, and reactive to light, without afferent pupil defect. Extraocular motilities showed full range of motion OU, and the patient denied experiencing diplopia. Confrontation visual fields were full to counting fingers OU. Color vision was normal with Hardy-Rand-Rittler testing OU. The patient’s anterior segment was also normal for her age OU.

The State of Optometry’s Financial Health

Five takeaways from the largest income survey conducted in optometry.

Aaron Neufeld, OD

Modern Optometry

Vision Correction Guidelines for Patients Approaching Presbyopia

Boost your multifocal contact lens fitting rates with effective patient engagement.

Osama Said, OD

Modern Optometry

Don’t “Lump” All Lid Lesions Together

Be thorough in creating your differential diagnosis.

Jacob Lang, OD, FAAO

Modern Optometry

Are Your Patients Solar Eclipse-Savvy?

It’s likely they need to be educated about safe viewing options.

Modern Optometry

Managing Keratoconus With Scleral Lenses

Advances in technology have driven significant improvements in patient care and outcomes.

Jason E. Compton, OD, FAAO

Modern Optometry

04.10.2024

Orbis Partners and Heidelberg Engineering Partner to Train Eye Care Professionals Around the World

Eyewire News

04.09.2024

Oasis Medical Introduces SOFT PLUG Extended Duration 180-T Tapered Plug

Eyewire News

04.05.2024

Wearing Glasses Boosts Income by a Third in Low-Income Communities, Finds Landmark New Study

Eyewire News

04.04.2024

Zeiss Completes Acquisition of Dutch Ophthalmic Research Center (DORC)

Eyewire News

Business

Changing the Perception of the Retail Optometrist

It’s time we broaden our perspectives on the possibilities of providing care in this setting.

Harmin Chima, OD, and John Womack, OD

Modern Optometry

Picture a familiar scene in a busy eye care clinic: An optometrist assures a relieved patient they don’t have glaucoma while reviewing their OCT results in the exam lane. The OD swiftly walks to the room next door to begin expressing the meibomian glands of another patient who is undergoing treatment for dry eye disease. Ten minutes and 25 questions about dry eye later, and the optometrist is heading back to the first exam lane to check on an 11-year-old boy who has been in a myopia control treatment program for 6 months. On the way there, a patient in the optical asks whether the red or tortoiseshell frame looks better on her. Add in 10 to 15 comprehensive examinations, several of which also require a contact lens fitting, and what you end up with is a typical day at work for many optometrists. As you were reading the above, were you imagining a retail optometric setting? If not, then you’re not alone—and that’s the purpose of this article—to let our private practice and academic colleagues know that our concept of retail optometry may be outdated. RECOGNIZING OUR PATIENTS’ NEEDS We practice at a franchise group that owns and operates 88 Pearle Vision locations across the country. One of us (JW) serves as the chief medical officer, and the other (HC) as vice president of Professional Services. Our roles come with many responsibilities, one of which, fortunately, is seeing patients so that we can remain clinically relevant.

Achieving Staffing Excellence

Master this cornerstone of practice success by defining each staff member’s specific role.

Jason E. Compton, OD, FAAO

Modern Optometry

Expand Your Opportunities for Profitability

Consider adding these technologies to your practice and reap the rewards.

Christopher Lopez, OD

Modern Optometry

Five Retina Coding Updates for 2024

Enter the new year with a better understanding of what to expect in your billing department.

Joy Woodke, COE, OCS, OCSR

Retina Today

Want to Achieve Financial Freedom?

Follow these four tips suitable for any optometrist.

Aaron Neufeld, OD

Modern Optometry

The Good Life

Selina R. McGee, OD, FAAO; Justin Schweitzer, OD, FAAO; and Walter O. Whitley, OD, MBA, FAAO

Modern Optometry

04.16.2024

Regeneron Backs $500 Million Venture Capital Fund for Biotechnology Innovation

Eyewire News

04.16.2024

EyeSouth Partners Affiliates With Community Eye Care Specialists in New York

Eyewire News

04.15.2024

Ocular Therapeutix Names Pravin U. Dugel, MD, President and CEO

Eyewire News

04.12.2024

False Claims Act Complaint Filed Against Regeneron for Fraudulent Drug Pricing Reporting

Eyewire News

EyewireTV

04.17.2024

04.17.2024

Executive Updates

Bausch + Lomb

Alcon

AbbVie

Tarsus Pharmaceuticals

Centricity Vision

Sydnexis

Azura Ophthalmics

iOR Partners

Eyewire News

BVI’s Podeye Hydrophobic Monofocal IOL Launched in Japan

Ocugen Completes Dosing in Phase 1/2 Trial of OCU410 for Geographic Atrophy

Ocular Therapeutix Releases Topline Results for Phase 1 Trial of Axpaxli for Diabetic Retinopathy

Stocks

Cataract

Dead Bag Syndrome

Capsular Bag: A New Site for Drug Delivery

Dense Cataract in Pseudoexfoliation Syndrome

A Model for Green Cataract Surgery

Artificial Intelligence Assisted Eye Care

The Consumer Journey in Vision Correction

04.19.2024

BVI’s Podeye Hydrophobic Monofocal IOL Launched in Japan

04.15.2024

Ocular Therapeutix Names Pravin U. Dugel, MD, President and CEO

04.12.2024

Robotic Cataract Surgery Using ForSight Robotics’ Oryom Platform Presented for the First Time at ASCRS

04.09.2024

Oasis Medical Introduces SOFT PLUG Extended Duration 180-T Tapered Plug

Refractive

Essential Preoperative Considerations

The Consumer Journey in Vision Correction

High Astigmatism With Underlying Ectasia

Synergizing Anterior and Posterior Expertise

Shaking Things Up

Treating Astigmatism With Femtosecond Laser

04.15.2024

Ocular Therapeutix Names Pravin U. Dugel, MD, President and CEO

04.11.2024

First Patient Enrolled in LYNX-2 Phase 3 Study Evaluating Phentolamine for the Treatment of Decreased VA Under Low Light Conditions Following Keratorefractive Surgery

04.09.2024

Oasis Medical Introduces SOFT PLUG Extended Duration 180-T Tapered Plug

04.04.2024

Zeiss Completes Acquisition of Dutch Ophthalmic Research Center (DORC)

Stay Updated

Follow Eyewire News

Retina

Tailoring IVT Dosing With Vitreous Volume

Managing Large Macular Holes: ILM Flap vs Peel

New Retina Radio Journal Club with VBS: Comparison of Antiseptics Use for IVT

Acute-Onset Vogt-Koyanagi-Harada Syndrome

A Reference Guide for OCT Angiography

Research Considerations During Retina Fellowship

04.19.2024

Ocugen Completes Dosing in Phase 1/2 Trial of OCU410 for Geographic Atrophy

04.18.2024

Ocular Therapeutix Releases Topline Results for Phase 1 Trial of Axpaxli for Diabetic Retinopathy

04.16.2024

Regeneron Backs $500 Million Venture Capital Fund for Biotechnology Innovation

04.15.2024

iHealthScreen Awarded US Patent on Glaucoma Detection Based on AI and Color Fundus Imaging

Glaucoma

Is Glaucoma Policy Short-Sighted?

Hydrus Microstent Removal and Repositioning

Ethical Global Outreach in Residency Training

Seen & Heard

Ahmed DVX Prism for ORA and Hydrus Cases

Screening and Establishing a Diagnosis With OCT

04.15.2024

iHealthScreen Awarded US Patent on Glaucoma Detection Based on AI and Color Fundus Imaging

04.15.2024

Ocular Therapeutix Names Pravin U. Dugel, MD, President and CEO

04.11.2024

Sight Sciences Announces the Publication of Large-Scale, Real-World MIGS Study Demonstrating Aqueous Outflow Restorative Procedure with OMNI

04.09.2024

Oasis Medical Introduces SOFT PLUG Extended Duration 180-T Tapered Plug

Featured Podcasts